ADVB
Advanced Biomed Inc (ADVB)
Healthcare • NASDAQ • $6.19-14.03%
- Symbol
- ADVB
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Price
- $6.19
- Daily Change
- -14.03%
- Market Cap
- $10.12M
- Trailing P/E
- 1.76
- Forward P/E
- N/A
- 52W High
- $25.80
- 52W Low
- $3.61
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- N/A
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagulable state samples of tumor patients; A+SCDrop, a circulating tumor cell (CTC) single-cell capture device; and A+CellScan, an analyzer with an immunostaining chip for immunostaining/analysis of the AC-1000 product. The company also offers microfluidic biochips, such as A+Pre, AC-1000 CTC enrichment, and A+CellScan chips to provide assay products and services to cancer patients. In addition, its imm…
Company websiteResearch ADVB on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.